# Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid

**Authors:** Kayadri Ratnarajah, Steffie Arès, Elio Kechichian, Carolina Lucena Fernandes

PMC · DOI: 10.1016/j.jdcr.2025.08.001 · 2025-08-19

## Full-text entities

- **Diseases:** bullous pemphigoid (MESH:D010391)
- **Chemicals:** mycophenolate mofetil (MESH:D009173), dupilumab (MESH:C582203), omalizumab (MESH:D000069444)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12547818/full.md

---
Source: https://tomesphere.com/paper/PMC12547818